866-997-4948(US-Canada Toll Free)

United States Influenza Medication Market Report 2017

Published By :

QYResearch

Published Date : Apr 2017

Category :

Pharmaceutical

No. of Pages : 102 Pages

In this report, the United States Influenza Medication market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Influenza Medication in these regions, from 2012 to 2022 (forecast).

United States Influenza Medication market competition by top manufacturers/players, with Influenza Medication sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Bristol-Myers Squibb
AstraZeneca
Eli Lilly
Roche
GSK
Novartis
Pfizer
Sanofi
Bayer
Celgene

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Typical Influenza Medication
Light Influenza Medication
Pneumonia Influenza Medication
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Influenza Medication for each application, including
Hospital
Clinic
Pharmacy
Other

Table of Contents

United States Influenza Medication Market Report 2017
1 Influenza Medication Overview
1.1 Product Overview and Scope of Influenza Medication
1.2 Classification of Influenza Medication by Product Category
1.2.1 United States Influenza Medication Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Influenza Medication Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Typical Influenza Medication
1.2.4 Light Influenza Medication
1.2.5 Pneumonia Influenza Medication
1.3 United States Influenza Medication Market by Application/End Users
1.3.1 United States Influenza Medication Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Other
1.4 United States Influenza Medication Market by Region
1.4.1 United States Influenza Medication Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Influenza Medication Status and Prospect (2012-2022)
1.4.3 Southwest Influenza Medication Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Influenza Medication Status and Prospect (2012-2022)
1.4.5 New England Influenza Medication Status and Prospect (2012-2022)
1.4.6 The South Influenza Medication Status and Prospect (2012-2022)
1.4.7 The Midwest Influenza Medication Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Influenza Medication (2012-2022)
1.5.1 United States Influenza Medication Sales and Growth Rate (2012-2022)
1.5.2 United States Influenza Medication Revenue and Growth Rate (2012-2022)

2 United States Influenza Medication Market Competition by Players/Suppliers
2.1 United States Influenza Medication Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Influenza Medication Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Influenza Medication Average Price by Players/Suppliers (2012-2017)
2.4 United States Influenza Medication Market Competitive Situation and Trends
2.4.1 United States Influenza Medication Market Concentration Rate
2.4.2 United States Influenza Medication Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Influenza Medication Manufacturing Base Distribution, Sales Area, Product Type

3 United States Influenza Medication Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Influenza Medication Sales and Market Share by Region (2012-2017)
3.2 United States Influenza Medication Revenue and Market Share by Region (2012-2017)
3.3 United States Influenza Medication Price by Region (2012-2017)

4 United States Influenza Medication Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Influenza Medication Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Influenza Medication Revenue and Market Share by Type (2012-2017)
4.3 United States Influenza Medication Price by Type (2012-2017)
4.4 United States Influenza Medication Sales Growth Rate by Type (2012-2017)

5 United States Influenza Medication Sales (Volume) by Application (2012-2017)
5.1 United States Influenza Medication Sales and Market Share by Application (2012-2017)
5.2 United States Influenza Medication Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Influenza Medication Players/Suppliers Profiles and Sales Data
6.1 Bristol-Myers Squibb
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Influenza Medication Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Bristol-Myers Squibb Influenza Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 AstraZeneca
6.2.2 Influenza Medication Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 AstraZeneca Influenza Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Eli Lilly
6.3.2 Influenza Medication Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Eli Lilly Influenza Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Roche
6.4.2 Influenza Medication Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Roche Influenza Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 GSK
6.5.2 Influenza Medication Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 GSK Influenza Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Novartis
6.6.2 Influenza Medication Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Novartis Influenza Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Pfizer
6.7.2 Influenza Medication Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Pfizer Influenza Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Sanofi
6.8.2 Influenza Medication Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Sanofi Influenza Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Bayer
6.9.2 Influenza Medication Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Bayer Influenza Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Celgene
6.10.2 Influenza Medication Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Celgene Influenza Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Influenza Medication Manufacturing Cost Analysis
7.1 Influenza Medication Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Influenza Medication

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Influenza Medication Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Influenza Medication Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Influenza Medication Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Influenza Medication Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Influenza Medication Sales Volume Forecast by Type (2017-2022)
11.3 United States Influenza Medication Sales Volume Forecast by Application (2017-2022)
11.4 United States Influenza Medication Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Influenza Medication
Figure United States Influenza Medication Market Size (K Pcs) by Type (2012-2022)
Figure United States Influenza Medication Sales Volume Market Share by Type (Product Category) in 2016
Figure Typical Influenza Medication Product Picture
Figure Light Influenza Medication Product Picture
Figure Pneumonia Influenza Medication Product Picture
Figure United States Influenza Medication Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Influenza Medication by Application in 2016
Figure Hospital Examples
Figure Clinic Examples
Figure Pharmacy Examples
Figure Other Examples
Figure United States Influenza Medication Market Size (Million USD) by Region (2012-2022)
Figure The West Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Influenza Medication Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Influenza Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Influenza Medication Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Influenza Medication Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Influenza Medication Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Influenza Medication Sales Share by Players/Suppliers
Figure 2017 United States Influenza Medication Sales Share by Players/Suppliers
Figure United States Influenza Medication Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Influenza Medication Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Influenza Medication Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Influenza Medication Revenue Share by Players/Suppliers
Figure 2017 United States Influenza Medication Revenue Share by Players/Suppliers
Table United States Market Influenza Medication Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Influenza Medication Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Influenza Medication Market Share of Top 3 Players/Suppliers
Figure United States Influenza Medication Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Influenza Medication Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Influenza Medication Product Category
Table United States Influenza Medication Sales (K Pcs) by Region (2012-2017)
Table United States Influenza Medication Sales Share by Region (2012-2017)
Figure United States Influenza Medication Sales Share by Region (2012-2017)
Figure United States Influenza Medication Sales Market Share by Region in 2016
Table United States Influenza Medication Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Influenza Medication Revenue Share by Region (2012-2017)
Figure United States Influenza Medication Revenue Market Share by Region (2012-2017)
Figure United States Influenza Medication Revenue Market Share by Region in 2016
Table United States Influenza Medication Price (USD/Pcs) by Region (2012-2017)
Table United States Influenza Medication Sales (K Pcs) by Type (2012-2017)
Table United States Influenza Medication Sales Share by Type (2012-2017)
Figure United States Influenza Medication Sales Share by Type (2012-2017)
Figure United States Influenza Medication Sales Market Share by Type in 2016
Table United States Influenza Medication Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Influenza Medication Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Influenza Medication by Type (2012-2017)
Figure Revenue Market Share of Influenza Medication by Type in 2016
Table United States Influenza Medication Price (USD/Pcs) by Types (2012-2017)
Figure United States Influenza Medication Sales Growth Rate by Type (2012-2017)
Table United States Influenza Medication Sales (K Pcs) by Application (2012-2017)
Table United States Influenza Medication Sales Market Share by Application (2012-2017)
Figure United States Influenza Medication Sales Market Share by Application (2012-2017)
Figure United States Influenza Medication Sales Market Share by Application in 2016
Table United States Influenza Medication Sales Growth Rate by Application (2012-2017)
Figure United States Influenza Medication Sales Growth Rate by Application (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Influenza Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Influenza Medication Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Influenza Medication Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Influenza Medication Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Influenza Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AstraZeneca Influenza Medication Sales Growth Rate (2012-2017)
Figure AstraZeneca Influenza Medication Sales Market Share in United States (2012-2017)
Figure AstraZeneca Influenza Medication Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Influenza Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly Influenza Medication Sales Growth Rate (2012-2017)
Figure Eli Lilly Influenza Medication Sales Market Share in United States (2012-2017)
Figure Eli Lilly Influenza Medication Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche Influenza Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Roche Influenza Medication Sales Growth Rate (2012-2017)
Figure Roche Influenza Medication Sales Market Share in United States (2012-2017)
Figure Roche Influenza Medication Revenue Market Share in United States (2012-2017)
Table GSK Basic Information List
Table GSK Influenza Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GSK Influenza Medication Sales Growth Rate (2012-2017)
Figure GSK Influenza Medication Sales Market Share in United States (2012-2017)
Figure GSK Influenza Medication Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Influenza Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Influenza Medication Sales Growth Rate (2012-2017)
Figure Novartis Influenza Medication Sales Market Share in United States (2012-2017)
Figure Novartis Influenza Medication Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Influenza Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Influenza Medication Sales Growth Rate (2012-2017)
Figure Pfizer Influenza Medication Sales Market Share in United States (2012-2017)
Figure Pfizer Influenza Medication Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Influenza Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Influenza Medication Sales Growth Rate (2012-2017)
Figure Sanofi Influenza Medication Sales Market Share in United States (2012-2017)
Figure Sanofi Influenza Medication Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Influenza Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer Influenza Medication Sales Growth Rate (2012-2017)
Figure Bayer Influenza Medication Sales Market Share in United States (2012-2017)
Figure Bayer Influenza Medication Revenue Market Share in United States (2012-2017)
Table Celgene Basic Information List
Table Celgene Influenza Medication Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Celgene Influenza Medication Sales Growth Rate (2012-2017)
Figure Celgene Influenza Medication Sales Market Share in United States (2012-2017)
Figure Celgene Influenza Medication Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Influenza Medication
Figure Manufacturing Process Analysis of Influenza Medication
Figure Influenza Medication Industrial Chain Analysis
Table Raw Materials Sources of Influenza Medication Major Players/Suppliers in 2016
Table Major Buyers of Influenza Medication
Table Distributors/Traders List
Figure United States Influenza Medication Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Influenza Medication Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Influenza Medication Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Influenza Medication Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Influenza Medication Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Influenza Medication Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Influenza Medication Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Influenza Medication Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Influenza Medication Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Influenza Medication Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Influenza Medication Sales Volume Share Forecast by Region (2017-2022)
Figure United States Influenza Medication Sales Volume Share Forecast by Region (2017-2022)
Figure United States Influenza Medication Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *